Authors:
OKUDA K
XIN KQ
TSUJI T
BUKAWA H
TANAKA S
KOFF WC
TANI K
OKUDA K
HONMA K
KAWAMOTO S
HAMAJIMA K
FUKUSHIMA J
Citation: K. Okuda et al., DNA VACCINATION FOLLOWED BY MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINATION AGAINST HIV-1 INDUCES STRONG ANTIGEN-SPECIFIC IMMUNITY, Vaccine, 15(10), 1997, pp. 1049-1056
Authors:
LI DF
FORREST BD
LI ZR
XUE P
HANSON CV
DUAN S
CHENG HH
LI ML
WANG CY
KOFF WC
Citation: Df. Li et al., INTERNATIONAL CLINICAL-TRIALS OF HIV VACCINES .2. PHASE-I TRIAL OF ANHIV-1 SYNTHETIC PEPTIDE VACCINE EVALUATING AN ACCELERATED IMMUNIZATION SCHEDULE IN YUNNAN, CHINA, Asian Pacific Journal of Allergy and Immunology, 15(2), 1997, pp. 105-113
Authors:
PHANUPHAK P
TEERATAKULPIXARN S
SARANGBIN S
NOOKHAI S
UBOLYAM S
SIRIVICHAYAKUL S
LEESAVAN A
FORREST BD
HANSON CV
LI ML
WANG CY
KOFF WC
Citation: P. Phanuphak et al., INTERNATIONAL CLINICAL-TRIALS OF HIV VACCINES .1. PHASE-I TRIAL OF ANHIV-1 SYNTHETIC PEPTIDE VACCINE IN BANGKOK, THAILAND, Asian Pacific Journal of Allergy and Immunology, 15(1), 1997, pp. 41-48
Authors:
TSUJI T
HAMAJIMA K
FUKUSHIMA J
XIN KQ
ISHII N
AOKI I
ISHIGATSUBO Y
TANI K
KAWAMOTO S
NITTA Y
MIYAZAKI J
KOFF WC
OKUBO T
OKUDA K
Citation: T. Tsuji et al., ENHANCEMENT OF CELL-MEDIATED-IMMUNITY AGAINST HIV-1 INDUCED BY COINOCULATION OF PLASMID-ENCODED HIV-1 ANTIGEN WITH PLASMID EXPRESSING IL-12, The Journal of immunology, 158(8), 1997, pp. 4008-4013
Citation: Wc. Koff et Am. Schultz, PROGRESS AND CHALLENGES TOWARD AN AIDS VACCINE - BROTHER, CAN YOU SPARE A PARADIGM, Journal of clinical immunology, 16(3), 1996, pp. 127-133
Authors:
GORSE GJ
KEEFER MC
BELSHE RB
MATTHEWS TJ
FORREST BD
HSIEH RH
KOFF WC
HANSON CV
DOLIN R
WEINHOLD KJ
FREY SE
KETTER N
FAST PE
Citation: Gj. Gorse et al., A DOSE-RANGING STUDY OF A PROTOTYPE SYNTHETIC HIV-1(MN) V3 BRANCHED PEPTIDE VACCINE, The Journal of infectious diseases, 173(2), 1996, pp. 330-339
Authors:
NIXON DF
DECHEN P
KUEBIER PJ
HIOE C
ZAMB T
MCGEE JP
OHAGAN DT
QUI H
LI J
WANG CY
KOFF WC
Citation: Df. Nixon et al., COMPARISON OF FORMULATIONS FOR INDUCTION OF CTL RESPONSES USING SYNTHETIC PEPTIDES, Journal of cellular biochemistry, 1995, pp. 313-313
Authors:
OHAGAN DT
MCGEE JP
BOYLE R
GUMAER D
LI XM
POTTS B
WANG CY
KOFF WC
Citation: Dt. Ohagan et al., THE PREPARATION, CHARACTERIZATION AND PRECLINICAL EVALUATION OF AN ORALLY-ADMINISTERED HIV-1 VACCINE, CONSISTING OF A BRANCHED PEPTIDE IMMUNOGEN ENTRAPPED IN CONTROLLED-RELEASE MICROPARTICLES, Journal of controlled release, 36(1-2), 1995, pp. 75-84
Authors:
KOFF WC
WALFIELD AM
LI ML
QIU H
BOYLE R
POTTS B
FORREST B
NIXON D
ZAMB T
MCGEE P
OHAGAN D
WANG CY
Citation: Wc. Koff et al., CURRENT STATUS OF UBI(R) SYNTHETIC PEPTIDE HIV VACCINE, AIDS research and human retroviruses, 10, 1994, pp. 190000048-190000048